Fideuram - Intesa Sanpaolo Private Banking’s ResMed RMD Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440K	Buy	+2,256	New	+$468K	0.01%	339

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's RMD Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking opened a new position in ResMed (RMD) in Q2 2026: 2,256 shares worth $440K. The stake represents 0.01% of the portfolio and ranks #339 among its holdings.

882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Fideuram - Intesa Sanpaolo Private Banking held 2,256 shares of ResMed worth $440K as of Q2 2026.
ResMed was a new Fideuram - Intesa Sanpaolo Private Banking position in Q2 2026.
ResMed made up 0.01% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #339 holding.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.